Phase 1/2 Trial to Test Phage Therapy for Chronic P. aeruginosa Infections

Phase 1/2 Trial to Test Phage Therapy for Chronic P. aeruginosa Infections

282519

Phase 1/2 Trial to Test Phage Therapy for Chronic P. aeruginosa Infections

A Phase 1/2 clinical trial, called CYPHY, to evaluate the phage therapy YPT-01 in treating chronic Pseudomonas aeruginosa infections in people with cystic fibrosis (CF) has been initiated at Yale University. This double-blind, placebo-controlled study (NCT 04684641) aims to enroll 36 adult patients with these chronic infections. Additional information and trial contacts are available here. P. aeruginosa is a bacteria that can cause serious lung infections in people with CF. While antibiotics can effectively treat some…

You must be logged in to read/download the full post.